Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06984250

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy

Official title: Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer

Key Details

Gender

FEMALE

Age Range

20 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

315

Start Date

2025-02-06

Completion Date

2030-02-28

Last Updated

2025-05-22

Healthy Volunteers

No

Interventions

RADIATION

Hypofractionated Radiation Therapy

Hypofractionated breast radiotherapy (HFRT) with hybrid techniques combining field-in-field intensity-modulated RT (FIF-IMRT) to the whole breast with inverse-IMRT for concomitant boost

Locations (2)

National Taiwan University Hospital

Taipei, Taiwan, Taiwan

National Taiwan University Hospital Yunlin Branch

Taipei, Taiwan